Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GUSELKUMAB for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 11 adverse event reports in the FDA FAERS database where GUSELKUMAB was used for Dermatitis.

Most Reported Side Effects for GUSELKUMAB

Side Effect Reports % Deaths Hosp.
Product dose omission issue 9,267 33.1% 2 78
Accidental exposure to product 2,941 10.5% 0 16
Drug ineffective 1,971 7.0% 8 61
Needle issue 1,933 6.9% 0 9
Psoriasis 1,817 6.5% 4 115
Device issue 1,613 5.8% 0 7
Device malfunction 1,410 5.0% 0 4
Off label use 1,186 4.2% 8 90
Product storage error 1,017 3.6% 1 11
Inappropriate schedule of product administration 830 3.0% 1 21
Device deployment issue 778 2.8% 0 4
Pneumonia 767 2.7% 21 273
Device leakage 712 2.5% 0 2
Arthralgia 709 2.5% 1 32
Drug delivery system malfunction 686 2.5% 0 9

Other Indications for GUSELKUMAB

Product used for unknown indication (12,308) Psoriasis (11,736) Psoriatic arthropathy (3,380) Colitis ulcerative (384) Crohn's disease (286) Rheumatoid arthritis (149) Palmoplantar pustulosis (72) Arthritis (64) Pustular psoriasis (60) Hidradenitis (51)

Other Drugs Used for Dermatitis

DUPILUMAB (9,959) CRISABOROLE (407) APREMILAST (122) TRALOKINUMAB-LDRM (90) KETOCONAZOLE (66) CYCLOSPORINE (62) DOXYCYCLINE (57) PIMECROLIMUS (55) CLOBETASOL (50) RUXOLITINIB (50)

Related Pages

GUSELKUMAB Full Profile All Dermatitis Drugs GUSELKUMAB Demographics GUSELKUMAB Timeline